Drug intelligence / Profile preview

amlodipine + folic acid

Development stage
Phase 4
Lead developer
Shenzhen Ausa Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Amlodipine + folic acid is a fixed-dose combination oral tablet containing the calcium channel blocker amlodipine and the water-soluble vitamin folic acid. This combination is primarily indicated for the treatment of essential hypertension, particularly in patients with hyperhomocysteinemia. Amlodipine acts as a voltage-gated calcium channel blocker, leading to vasodilation and blood pressure reduction. Folic acid participates in homocysteine metabolism, lowering plasma homocysteine levels—a risk factor for cardiovascular disease. Clinical studies have shown that this combination is more effective than amlodipine alone at reducing both blood pressure and plasma homocysteine levels, potentially offering additional protection against complications such as stroke[1][2][5][8].

Other names
amlodipine‐folic acid
02

Targets

DHFR (Dihydrofolate reductase)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on amlodipine + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amlodipine + folic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call